Fermer le menu


Member of Lyonbiopole


Development of antivirals EBV infections. Main objective is the control of the activation and immortalization of B cells following infection with EBV for providing new treatment for EBV-associated diseases that include post-transplantation lymphoproliferative diseases, lymphomas, and multiple sclerosis.


Strategic application domain: Human Medicine

Application market: Hematology, Infectious Diseases, Neurology & Mental Health Disorders

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Small Molecules

Created on oct. 9th, 2020 - 2 employees



321 avenue Tony Garnier 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.